No. 4 Medical Innovation for 2020: Therapy for Peanut Allergies

Oral immunotherapy drug is first of its kind

About 8% of U.S. children have a food allergy, and that number is on the rise. Avoiding the allergic trigger is recommended, but it’s not always possible.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

Desensitization therapy, while not a cure, may alleviate some fear of accidental exposure by training the immune system to adapt.

In September 2019, an FDA expert panel recommended approval of a first-of-its-kind treatment — an oral immunotherapy medication to gradually build tolerance to peanut exposure.

In this video, learn more about why this therapy for peanut allergies is one of Cleveland Clinic’s Top 10 Medical Innovations for 2020.

Advertising Policy